Independent minds. Global perspective. A publication for the builders
Biotechnology / San Francisco

Jose Miguel Hernandez Lobato.

Co-founder
Ångström AI

Jose Miguel Hernandez Lobato is a founder of Ångström AI and a machine learning professor at Cambridge. His research background includes a postdoctoral role at Harvard and work on modelling molecules. The company's founding team combines academic expertise in machine learning, physics and molecular simulation for pharmaceutical and biotechnology research.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Jose Miguel Hernandez Lobato and the story of Ångström AI.

Ångström's launch describes combining a detailed physics model with generative methods intended to reduce the computational effort of molecular simulations. The founders distinguish generating physically consistent states from simulating every transition through a conventional method. This is a technical research direction with laboratory comparisons cited in the source. It should not be simplified into proof that computation can establish a drug's clinical safety or replace all experiments, and the advertised acceleration remains context dependent.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Ångström AI — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗